These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26628614)

  • 41. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.
    Vaisman BL; Neufeld EB; Freeman LA; Gordon SM; Sampson ML; Pryor M; Hillman E; Axley MJ; Karathanasis SK; Remaley AT
    J Pharmacol Exp Ther; 2019 Mar; 368(3):423-434. PubMed ID: 30563940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LCAT- targeted therapies: Progress, failures and future.
    Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
    Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer.
    Mihajlovic M; Gojkovic T; Vladimirov S; Miljkovic M; Stefanovic A; Vekic J; Zeljkovic D; Trifunovic B; Kotur-Stevuljevic J; Spasojevic-Kalimanovska V; Zeljkovic A
    Clin Biochem; 2019 Jan; 63():32-38. PubMed ID: 30500525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo.
    Tomimoto S; Tsujita M; Okazaki M; Usui S; Tada T; Fukutomi T; Ito S; Itoh M; Yokoyama S
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):394-400. PubMed ID: 11231919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency.
    Kuroda M; Holleboom AG; Stroes ES; Asada S; Aoyagi Y; Kamata K; Yamashita S; Ishibashi S; Saito Y; Bujo H
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1756-62. PubMed ID: 24876348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
    Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
    Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lecithin: cholesterol acyl transfer rate in plasma and its relation to lipid and lipoprotein concentrations in primary hyperlipidemia.
    Wallentin L
    Atherosclerosis; 1977 Feb; 26(2):233-48. PubMed ID: 189784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of high density lipoprotein composition to plasma lecithin:cholesterol acyltransferase concentration in men.
    Miller NE; Rajput-Williams J; Nanjee MN; Samuel L; Albers JJ
    Atherosclerosis; 1988 Feb; 69(2-3):123-9. PubMed ID: 3126747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L
    Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
    Lambert G; Sakai N; Vaisman BL; Neufeld EB; Marteyn B; Chan CC; Paigen B; Lupia E; Thomas A; Striker LJ; Blanchette-Mackie J; Csako G; Brady JN; Costello R; Striker GE; Remaley AT; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 2001 May; 276(18):15090-8. PubMed ID: 11278414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.
    Freeman LA; Shamburek RD; Sampson ML; Neufeld EB; Sato M; Karathanasis SK; Remaley AT
    J Lipid Res; 2019 May; 60(5):1050-1057. PubMed ID: 30808683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lecithin:cholesterol acyltransferase activity, plasma and lipoprotein lipids and obesity in men and women.
    Sutherland WH; Temple WA; Nye ER; Herbison PG
    Atherosclerosis; 1979 Nov; 34(3):319-27. PubMed ID: 518742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
    Bonaca MP; Morrow DA; Bergmark BA; Berg DD; Lima JAC; Hoffmann U; Kato Y; Lu MT; Kuder J; Murphy SA; Spinar J; Oude Ophuis T; Kiss RG; Lopez-Sendon J; Averkov O; Wheatcroft SB; Kubica J; Carlos Nicolau J; Furtado RHM; Abuhatzira L; Hirshberg B; Omar SA; Vavere AL; Chang YT; George RT; Sabatine MS
    Circulation; 2022 Sep; 146(12):907-916. PubMed ID: 36039762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.
    Freeman LA; Demosky SJ; Konaklieva M; Kuskovsky R; Aponte A; Ossoli AF; Gordon SM; Koby RF; Manthei KA; Shen M; Vaisman BL; Shamburek RD; Jadhav A; Calabresi L; Gucek M; Tesmer JJG; Levine RL; Remaley AT
    J Pharmacol Exp Ther; 2017 Aug; 362(2):306-318. PubMed ID: 28576974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.
    Ishibashi R; Takemoto M; Tsurutani Y; Kuroda M; Ogawa M; Wakabayashi H; Uesugi N; Nagata M; Imai N; Hattori A; Sakamoto K; Kitamoto T; Maezawa Y; Narita I; Hiroi S; Furuta A; Miida T; Yokote K
    J Clin Lipidol; 2018; 12(4):888-897.e2. PubMed ID: 29937398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lecithin:cholesterol acyl transfer in plasma of normal persons in relation to lipid and lipoprotein concentration.
    Wallentin L; Vikrot O
    Scand J Clin Lab Invest; 1975 Nov; 35(7):669-76. PubMed ID: 174186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation.
    McPherson PA; Young IS; McEneny J
    Free Radic Biol Med; 2007 Dec; 43(11):1484-93. PubMed ID: 17964419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Action of lecithin-cholesterol acyltransferase on low-density lipoproteins in native pig plasma.
    Knipping G; Birchbauer A; Steyrer E; Kostner GM
    Biochemistry; 1987 Dec; 26(24):7945-53. PubMed ID: 3427116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis.
    Klein HG; Santamarina-Fojo S; Duverger N; Clerc M; Dumon MF; Albers JJ; Marcovina S; Brewer HB
    J Clin Invest; 1993 Jul; 92(1):479-85. PubMed ID: 8326012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of ethanol on lecithin:cholesterol acyltransferase (LCAT) activity.
    Mulligan JJ; Cluette-Brown JE; Noring R; Igoe FD; Chong J; Hojnacki JL
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):181-202. PubMed ID: 3992006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.